| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/21678421.2014.905606 |
| P698 | PubMed publication ID | 24834468 |
| P50 | author | Markus Otto | Q67390357 |
| Albert C. Ludolph | Q67390363 | ||
| Dietmar R. Thal | Q43145446 | ||
| P2093 | author name string | Paul Walther | |
| Petra Steinacker | |||
| Stefan Lehnert | |||
| Anja Schneider | |||
| Emily Feneberg | |||
| Miriam Linsenmeier | |||
| P2860 | cites work | iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia. | Q54530327 |
| Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? | Q21129257 | ||
| Classification of primary progressive aphasia and its variants | Q24594803 | ||
| Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 | ||
| B lymphocytes secrete antigen-presenting vesicles | Q24678522 | ||
| Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
| Exosomes: from biogenesis and secretion to biological function | Q28270550 | ||
| Membrane vesicles as conveyors of immune responses | Q29547765 | ||
| Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
| TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q29615597 | ||
| Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. | Q30805170 | ||
| Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease | Q33371612 | ||
| Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration | Q33601762 | ||
| Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management | Q34046590 | ||
| Protein size and cerebrospinal fluid composition | Q34210609 | ||
| Identification and proteomic profiling of exosomes in human cerebrospinal fluid | Q35744824 | ||
| TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration | Q36766654 | ||
| Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. | Q36991962 | ||
| The role of exosomes in the processing of proteins associated with neurodegenerative diseases | Q37026739 | ||
| TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q37213414 | ||
| Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy | Q37681653 | ||
| TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration. | Q37903416 | ||
| TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies | Q37904288 | ||
| Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders | Q38011636 | ||
| Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations | Q39811341 | ||
| Packaging of prions into exosomes is associated with a novel pathway of PrP processing. | Q40163902 | ||
| TDP-43 plasma levels are higher in amyotrophic lateral sclerosis | Q47290748 | ||
| Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases | Q48149510 | ||
| Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43. | Q48772618 | ||
| Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia. | Q53275555 | ||
| P433 | issue | 5-6 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| diagnosis | Q16644043 | ||
| P304 | page(s) | 351-356 | |
| P577 | publication date | 2014-05-16 | |
| P1433 | published in | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | Q23928840 |
| P1476 | title | Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases | |
| P478 | volume | 15 |
| Q93164263 | An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders |
| Q57461891 | Application of bioconjugation chemistry on biosensor fabrication for detection of TAR-DNA binding protein 43 |
| Q39251035 | Applying fluid biomarkers to Alzheimer's disease |
| Q89607097 | Assessment of separation methods for extracellular vesicles from human and mouse brain tissues and human cerebrospinal fluids |
| Q64079969 | Biomarkers in Motor Neuron Disease: A State of the Art Review |
| Q39413097 | Biomarkers in Neurodegenerative Diseases |
| Q98613045 | CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis |
| Q35750755 | Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis |
| Q47893862 | Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders. |
| Q36906403 | Cerebrospinal Fluid TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Patients with and without the C9ORF72 Hexanucleotide Expansion |
| Q47587631 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry |
| Q60310921 | Current state of Alzheimer's fluid biomarkers |
| Q58714289 | Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases |
| Q38743399 | Exosome secretion is a key pathway for clearance of pathological TDP-43. |
| Q39301571 | Exosomes and their Application in Biomedical Field: Difficulties and Advantages. |
| Q36577074 | Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine? |
| Q93108989 | Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases |
| Q99605512 | Extracellular Vesicles as Innovative Tool for Diagnosis, Regeneration and Protection against Neurological Damage |
| Q52309394 | Extracellular Vesicles: Packages Sent With Complement. |
| Q38795618 | Extracellular vesicles and intercellular communication within the nervous system |
| Q38833377 | Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers. |
| Q58120685 | Growth Hormone-Releasing Hormone Administration in Mild Cognitive Impairment and Its Impact on Neuronal Exosome Biomarkers of Dementia |
| Q51519602 | Impaired activation of ALS monocytes by exosomes. |
| Q64113405 | Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients |
| Q54946040 | Molecular biomarkers of Alzheimer's disease: progress and prospects. |
| Q26783410 | New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis |
| Q60529524 | Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients |
| Q39354673 | Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release? |
| Q89945308 | Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg |
| Q38922025 | Prion-like propagation as a pathogenic principle in frontotemporal dementia. |
| Q46285411 | Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD. |
| Q64899263 | Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD. |
| Q92310096 | Recent advances in understanding frontotemporal degeneration |
| Q58769480 | Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis |
| Q38690632 | Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease |
| Q55233896 | Synaptic Failure: Focus in an Integrative View of ALS. |
| Q35234677 | TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies |
| Q55517106 | TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. |
| Q36310560 | TDP-43 is intercellularly transmitted across axon terminals |
| Q38529627 | The Role of TDP-43 in Alzheimer's Disease |
| Q49823859 | Towards a TDP-43-Based Biomarker for ALS and FTLD. |
Search more.